The Metabolic Medicine Department at Salford Royal is one of the leading departments in Europe for Adult Inherited Metabolic Disorders.
It is one of only four dedicated Adult Inherited Metabolic Disorder centres within England, with patients coming from as far as Scotland, Wales, Newcastle, and the Isle of Man.
These rare genetic disorders are debilitating, disfiguring and life threatening and cause many complications for patients as well as challenges for families and carers.
Through our research, we are able to bring new treatments to patients, improving quality of life and giving hope for the future.
The Metabolic Medicine Research Department undertakes clinical trials into rare genetic disorders and is at the forefront of drug development studies.
Conditions being studied include:
- Cholesteryl Ester Storage Disorder (Lysosomal Acid Lipase (LAL) Deficiency
- Pompe disease
- Fabry disease
- Gaucher disease.
- Niemann Pick disease
We also work with physiotherapists and dietitians to investigate and improve future treatments for our patients.
The department is active within data registries for our patients, collecting information from disease diagnosis throughout the treatment of the patient. These registries assist doctors from all over the world to collaborate and adjust and improve the holistic treatment of our patients.
We work closely with the voluntary societies that support our patient groups:
For information on upcoming clinical trials within the department, academic studies and registries contact
Marie Meehan, Senior Clinical Research Practitioner/Trials Coordinator
0161 206 4192